DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth

DexCom is moving into the forefront in other ways. Its stock recently cleared a price consolidation above a $126.54 buy point.

Related Keywords

Boston ,Massachusetts ,United States ,Ascensia Diabetescare ,Nick Jonas ,Marketbeat Dexcom ,Pepsico Inc ,Medtronic Diabetes Group ,Zimmer Biomet Holdings Inc ,Roche Holding ,Dexcom Inc ,Centers For Medicare ,Medtronic ,Health Wellness ,Stryker Corp ,Medicaid Services ,Nasdaq ,Cola Co ,Boston Scientific Corp ,Prescriber And Patient ,Super Bowl ,Qualified Financial ,Excess Cash Flow Value Funds ,Boston Scientific ,Zimmer Biomet Holdings ,Diabetes Care ,Abbott Laboratories ,Diabetes Group ,Wall Street ,